Page 7 - Lykan Bioscience News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Lykan Bioscience Welcomes Keith McCormick as Chief Financial Officer News provided by Share this article Share this article HOPKINTON, Mass., Feb. 15, 2021 /PRNewswire/  Lykan Bioscience, a contract Manufacturing Services Organization™ (MSO) and provider of the first true end-to-end solution for the manufacture of cell-based therapies, welcomes Keith McCormick as Chief Financial Officer.  Keith brings more than 30 years of finance experience with leadership positions in several leading companies across a range of industries, geographies, and financial disciplines. As CFO, Keith is responsible for the integrity of the company s financial reporting and business control processes while partnering with the leadership team in all aspects of the company s management including strategy, contracting, investment, operations management and customer satisfaction.

United kingdomKeith mccormickLykan bioscienceOkim yangPatrick lucyPatheon pharmaceuticalsDevelopment servicesManufacturing services organizationChief financialThermo fisherPharmaceutical development servicesChartered accountantLykan bioscience presidentFuture togetherஒன்றுபட்டது கிஂக்டம்கேய்ட் ம்க்கார்‌மிக்